Analysts Set Synopsys, Inc. (NASDAQ:SNPS) Target Price at $639.58

Shares of Synopsys, Inc. (NASDAQ:SNPSGet Free Report) have been given an average recommendation of “Moderate Buy” by the twelve research firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $638.58.

A number of brokerages recently commented on SNPS. Robert W. Baird dropped their price target on Synopsys from $644.00 to $630.00 and set an “outperform” rating for the company in a research note on Thursday, December 5th. Piper Sandler decreased their price target on shares of Synopsys from $655.00 to $653.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Needham & Company LLC restated a “buy” rating and issued a $650.00 price objective on shares of Synopsys in a report on Thursday, February 27th. Redburn Atlantic assumed coverage on Synopsys in a report on Monday, January 13th. They set a “buy” rating and a $600.00 target price on the stock. Finally, Morgan Stanley lowered their target price on Synopsys from $625.00 to $590.00 and set an “overweight” rating for the company in a research note on Monday, February 24th.

View Our Latest Stock Report on SNPS

Synopsys Price Performance

SNPS opened at $447.96 on Thursday. The firm has a market capitalization of $69.26 billion, a price-to-earnings ratio of 30.85, a PEG ratio of 3.23 and a beta of 1.12. Synopsys has a one year low of $429.77 and a one year high of $624.80. The business has a 50 day simple moving average of $503.01 and a two-hundred day simple moving average of $513.56.

Insider Transactions at Synopsys

In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the sale, the executive now directly owns 1,460 shares in the company, valued at approximately $738,774.60. This trade represents a 93.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the business’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total value of $5,270,982.50. Following the completion of the transaction, the chief executive officer now owns 70,922 shares of the company’s stock, valued at $32,890,077.50. This represents a 13.81 % decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is owned by insiders.

Institutional Investors Weigh In On Synopsys

Several large investors have recently bought and sold shares of the business. Kieckhefer Group LLC bought a new stake in shares of Synopsys in the fourth quarter worth approximately $27,000. Ameriflex Group Inc. purchased a new stake in Synopsys in the fourth quarter worth approximately $29,000. Whipplewood Advisors LLC bought a new stake in Synopsys in the 4th quarter worth approximately $33,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in Synopsys during the 4th quarter valued at $34,000. Finally, Hazlett Burt & Watson Inc. lifted its holdings in shares of Synopsys by 40.0% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock valued at $35,000 after buying an additional 20 shares during the period. 85.47% of the stock is currently owned by institutional investors.

About Synopsys

(Get Free Report

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Stories

Analyst Recommendations for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.